Low-Dose Aspirin Fails in Primary Prevention

Susan Jeffrey

November 18, 2014
CHICAGO — A new trial shows no benefit of low-dose, once-daily aspirin in the primary prevention of cardiovascular events in patients with multiple risk factors, including hypertension, diabetes, and dyslipidemia.

Completo aquì:  http://www.medscape.com/viewarticle/835085?nlid=70788_2049&src=wnl_edit_medn_imed&uac=85318MZ&spon=18